Skip to main content
Brie Carter Photo
Brie Carter

Brie Carter

GrafaTV Presenter & Finance Editor

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.

Articles by Brie Carter

Grafa

European regulators accept Teva and Medincell’s application for long-acting Schizophrenia injection

Teva Pharmaceutical Industries (NYSE:TEVA) and Medincell announced Thursday that the European Medicines Agency has accepted their Marketing Authorization Application for TEV-749, an investigational long-acting injectable formulation designed to treat adults living with schizophrenia.

Read more: European regulators accept Teva and Medincell’s application for long-acting Schizophrenia injection
Grafa

Gilead extends WHO partnership to eliminate second-deadliest parasitic disease

Gilead Sciences (NASDAQ:GILD) announced a renewed five-year collaboration framework with the World Health Organization (WHO), extending an institutional partnership targeted at eliminating visceral leishmaniasis (VL) as a public health threat by 2030.

Read more: Gilead extends WHO partnership to eliminate second-deadliest parasitic disease